PAA 2.50% 20.5¢ pharmaust limited

Ann: Epichem's New Laboratory Completed, page-95

  1. 2,408 Posts.
    lightbulb Created with Sketch. 1494
    At this point in time I cannot see them making any more progress reports on PPL-1 trials, even in dogs, until the major report on the phase 1 human trials are released or the go ahead for the phase 2 clinical trials are announced, which I hope is soon(ish).
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.